160 related articles for article (PubMed ID: 12844270)
21. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
22. Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro.
Jones S; Manning J; Kad NM; Radford SE
J Mol Biol; 2003 Jan; 325(2):249-57. PubMed ID: 12488093
[TBL] [Abstract][Full Text] [Related]
23. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
24. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's amyloid fibrils: structure and assembly.
Serpell LC
Biochim Biophys Acta; 2000 Jul; 1502(1):16-30. PubMed ID: 10899428
[TBL] [Abstract][Full Text] [Related]
26. In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process.
Hernández-Rodríguez M; Correa-Basurto J; Benitez-Cardoza CG; Resendiz-Albor AA; Rosales-Hernández MC
Protein Sci; 2013 Oct; 22(10):1320-35. PubMed ID: 23904252
[TBL] [Abstract][Full Text] [Related]
27. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix.
Blake C; Serpell L
Structure; 1996 Aug; 4(8):989-98. PubMed ID: 8805583
[TBL] [Abstract][Full Text] [Related]
28. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
29. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
30. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
[TBL] [Abstract][Full Text] [Related]
31. The Brichos domain-containing C-terminal part of pro-surfactant protein C binds to an unfolded poly-val transmembrane segment.
Johansson H; Nordling K; Weaver TE; Johansson J
J Biol Chem; 2006 Jul; 281(30):21032-21039. PubMed ID: 16709565
[TBL] [Abstract][Full Text] [Related]
32. Molecular modeling of the amyloid-beta-peptide using the homology to a fragment of triosephosphate isomerase that forms amyloid in vitro.
Contreras CF; Canales MA; Alvarez A; De Ferrari GV; Inestrosa NC
Protein Eng; 1999 Nov; 12(11):959-66. PubMed ID: 10585501
[TBL] [Abstract][Full Text] [Related]
33. Stabilization of discordant helices in amyloid fibril-forming proteins.
Päiviö A; Nordling E; Kallberg Y; Thyberg J; Johansson J
Protein Sci; 2004 May; 13(5):1251-9. PubMed ID: 15096631
[TBL] [Abstract][Full Text] [Related]
34. A molecular model of Alzheimer amyloid beta-peptide fibril formation.
Tjernberg LO; Callaway DJ; Tjernberg A; Hahne S; Lilliehöök C; Terenius L; Thyberg J; Nordstedt C
J Biol Chem; 1999 Apr; 274(18):12619-25. PubMed ID: 10212241
[TBL] [Abstract][Full Text] [Related]
35. Optimum amyloid fibril formation of a peptide fragment suggests the amyloidogenic preference of beta2-microglobulin under physiological conditions.
Ohhashi Y; Hasegawa K; Naiki H; Goto Y
J Biol Chem; 2004 Mar; 279(11):10814-21. PubMed ID: 14699107
[TBL] [Abstract][Full Text] [Related]
36. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
37. Left-handed polyproline-II helix revisited: proteins causing proteopathies.
Adzhubei AA; Anashkina AA; Makarov AA
J Biomol Struct Dyn; 2017 Sep; 35(12):2701-2713. PubMed ID: 27562438
[TBL] [Abstract][Full Text] [Related]
38. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
39. Rationally designed mutations convert de novo amyloid-like fibrils into monomeric beta-sheet proteins.
Wang W; Hecht MH
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2760-5. PubMed ID: 11880628
[TBL] [Abstract][Full Text] [Related]
40. The BRICHOS domain, amyloid fibril formation, and their relationship.
Knight SD; Presto J; Linse S; Johansson J
Biochemistry; 2013 Oct; 52(43):7523-31. PubMed ID: 24099305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
